AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 185 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,558,936 | -14.7% | 168,434 | -15.4% | 0.00% | 0.0% |
Q1 2024 | $15,886,504 | +115.0% | 199,079 | +114.5% | 0.00% | +50.0% |
Q4 2023 | $7,388,419 | -15.8% | 92,831 | -26.1% | 0.00% | -33.3% |
Q3 2023 | $8,776,856 | -55.7% | 125,581 | -54.5% | 0.00% | -57.1% |
Q2 2023 | $19,826,317 | +1378.3% | 275,902 | +1168.9% | 0.01% | +600.0% |
Q1 2023 | $1,341,170 | -90.1% | 21,744 | -87.6% | 0.00% | -83.3% |
Q4 2022 | $13,567,090 | +66.3% | 175,899 | -3.8% | 0.01% | +50.0% |
Q3 2022 | $8,159,000 | +408.7% | 182,870 | +336.5% | 0.00% | +300.0% |
Q2 2022 | $1,604,000 | -79.0% | 41,895 | -77.3% | 0.00% | -66.7% |
Q1 2022 | $7,652,000 | -81.4% | 184,859 | -83.0% | 0.00% | -78.6% |
Q4 2021 | $41,049,000 | +71.1% | 1,086,494 | +49.3% | 0.01% | +75.0% |
Q3 2021 | $23,989,000 | -14.7% | 727,832 | +74.5% | 0.01% | -27.3% |
Q2 2021 | $28,139,000 | +5.0% | 417,111 | -11.8% | 0.01% | -15.4% |
Q1 2021 | $26,791,000 | -10.4% | 473,172 | +28.9% | 0.01% | -13.3% |
Q4 2020 | $29,896,000 | -36.3% | 366,954 | -44.3% | 0.02% | -48.3% |
Q3 2020 | $46,901,000 | +6.2% | 658,255 | +22.7% | 0.03% | -12.1% |
Q2 2020 | $44,154,000 | +148.4% | 536,639 | +77.6% | 0.03% | +94.1% |
Q1 2020 | $17,776,000 | -37.2% | 302,160 | +10.3% | 0.02% | -56.4% |
Q4 2019 | $28,306,000 | +11132.5% | 273,856 | +2099.6% | 0.04% | – |
Q3 2019 | $252,000 | -18.7% | 12,450 | +3.3% | 0.00% | -100.0% |
Q2 2019 | $310,000 | -66.0% | 12,058 | -81.2% | 0.00% | 0.0% |
Q1 2019 | $913,000 | – | 64,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |